Cargando…

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma

Background: Lung adenocarcinoma (LUAD) is a highly heterogeneous tumor with substantial somatic mutations and genome instability, which are emerging hallmarks of cancer. Long non-coding RNAs (lncRNAs) are promising cancer biomarkers that are reportedly involved in genomic instability. However, the i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geng, Wei, Lv, Zhilei, Fan, Jinshuo, Xu, Juanjuan, Mao, Kaimin, Yin, Zhengrong, Qing, Wanlu, Jin, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039462/ https://www.ncbi.nlm.nih.gov/pubmed/33855028 http://dx.doi.org/10.3389/fcell.2021.657667

Ejemplares similares

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
por: Zhang, Peiling, et al.
Publicado: (2021)

Oncogenic Landscape of Somatic Mutations Perturbing Pan-Cancer lncRNA-ceRNA Regulation
por: Zhang, Yuanfu, et al.
Publicado: (2021)

Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
por: Nie, Chuang, et al.
Publicado: (2022)

Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma
por: Zhang, Xu, et al.
Publicado: (2023)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma
por: Mao, Rui, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer
por: Liu, Jinhui, et al.
Publicado: (2022)

Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
por: Yang, Hao, et al.
Publicado: (2021)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
por: Chu, Yanjie, et al.
Publicado: (2020)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives
por: Xie, Luhan, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

M5C-Related lncRNA Predicts Lung Adenocarcinoma and Tumor Microenvironment Remodeling: Computational Biology and Basic Science
por: Bai, Ming, et al.
Publicado: (2022)

A lncRNA Perspective into (Re)Building the Heart
por: Frank, Stefan, et al.
Publicado: (2016)

LncRNA and its role in gastric cancer immunotherapy
por: Zhang, Qiang, et al.
Publicado: (2023)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer
por: Hu, Wei, et al.
Publicado: (2021)

Role of lncRNA BANCR in Human Cancers: An Updated Review
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2021)

Computational detection of a genome instability‐derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma
por: Guo, Chen‐Rui, et al.
Publicado: (2021)

MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
por: Yu, Xiao, et al.
Publicado: (2021)

Biological Function of Long Non-coding RNA (LncRNA) Xist
por: Wang, Wenlun, et al.
Publicado: (2021)

Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022)

A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer
por: Guo, Cheng, et al.
Publicado: (2021)

Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications
por: Lu, Xiaolin, et al.
Publicado: (2022)

Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
por: Yao, Qiuming, et al.
Publicado: (2021)

The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma
por: Hong, Yuling, et al.
Publicado: (2022)

Considerations when investigating lncRNA function in vivo
por: Bassett, Andrew R, et al.
Publicado: (2014)

Detection of Allosteric Effects of lncRNA Secondary Structures Altered by SNPs in Human Diseases
por: Lu, Xiaoyan, et al.
Publicado: (2020)

Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma
por: Zhang, Jiaqi, et al.
Publicado: (2020)

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
por: Zhang, Shujun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rp8sqavkbdpsapqod6e0b9ma3d